These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17625483)

  • 21. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
    Douaihy AB; Jou RJ; Gorske T; Salloum IM
    AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
    Heimer R
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):67-74. PubMed ID: 9722811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
    Coyle SL; Needle RH; Normand J
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):19-30. PubMed ID: 9722807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection and risk behaviors among heterosexuals in alcohol treatment programs.
    Avins AL; Woods WJ; Lindan CP; Hudes ES; Clark W; Hulley SB
    JAMA; 1994 Feb; 271(7):515-8. PubMed ID: 8301765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Nov; 61(RR-5):1-40. PubMed ID: 23135062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.
    Herbst JH; Raiford JL; Carry MG; Wilkes AL; Ellington RD; Whittier DK
    MMWR Suppl; 2016 Feb; 65(1):42-50. PubMed ID: 26916033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for HIV and hepatitis C virus infections in recreational drug users.
    Khalsa JH; Elkashef A
    Clin Infect Dis; 2010 Jun; 50(11):1505-11. PubMed ID: 20415569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies.
    Batkis MF; Treisman GJ; Angelino AF
    AIDS Patient Care STDS; 2010 Jan; 24(1):15-22. PubMed ID: 20095910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating HIV/AIDS and alcohol research.
    Bryant KJ; Nelson S; Braithwaite RS; Roach D
    Alcohol Res Health; 2010; 33(3):167-78. PubMed ID: 23584058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol Misuse and Illicit Drug Use Among Occupational Groups at High Risk of HIV in Sub-Saharan Africa: A Systematic Review.
    Kuteesa MO; Seeley J; Weiss HA; Cook S; Kamali A; Webb EL
    AIDS Behav; 2019 Dec; 23(12):3199-3225. PubMed ID: 30945031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention.
    Michel L; Carrieri MP; Fugon L; Roux P; Aubin HJ; Lert F; Obadia Y; Spire B;
    AIDS Care; 2010 Sep; 22(9):1136-45. PubMed ID: 20824566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol dependence and CD4 cell count: is there a relationship?
    Malbergier A; Amaral RA; Cardoso LD
    AIDS Care; 2015; 27(1):54-8. PubMed ID: 25179410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type and pattern of illicit drug use and access to health care services for HIV-infected people.
    Sohler NL; Wong MD; Cunningham WE; Cabral H; Drainoni ML; Cunningham CO
    AIDS Patient Care STDS; 2007; 21 Suppl 1():S68-76. PubMed ID: 17563292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?
    Fojo AT; Lesko CR; Calkins KL; Moore RD; McCaul ME; Hutton HE; Mathews WC; Crane H; Christopoulos K; Cropsey K; Mugavero MJ; Mayer K; Pence BW; Lau B; Chander G
    AIDS Behav; 2019 Mar; 23(3):580-591. PubMed ID: 30269230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not just the needle: the state of HIV-prevention science among substance users and future directions.
    Shoptaw S; Montgomery B; Williams CT; El-Bassel N; Aramrattana A; Metsch L; Metzger DS; Kuo I; Bastos FI; Strathdee SA
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S174-8. PubMed ID: 23764632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.